These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

90 related items for PubMed ID: 8917423

  • 1. Biochemical characterization of cisplatin-resistance in MKN-45 human stomach adenocarcinoma cell line.
    Hong WS, Son YS.
    Anticancer Res; 1996; 16(5A):3031-6. PubMed ID: 8917423
    [Abstract] [Full Text] [Related]

  • 2. Antitumor activity of DA-125, a novel anthracycline, in human gastric and pulmonary adenocarcinoma cells resistant to adriamycin and cisplatin.
    Hong WS, Jung HY, Yang SK, Kim HR, Min YI.
    Anticancer Res; 1997; 17(5A):3613-6. PubMed ID: 9413212
    [Abstract] [Full Text] [Related]

  • 3. Cisplatin-resistant human small cell lung cancer cell line shows collateral sensitivity to vinca alkaloids.
    Moritaka T, Kiura K, Ueoka H, Tabata M, Segawa Y, Shibayama T, Takigawa N, Ohnoshi T, Harada M.
    Anticancer Res; 1998; 18(2A):927-33. PubMed ID: 9615743
    [Abstract] [Full Text] [Related]

  • 4. Reduced activity of topoisomerase II in an Adriamycin-resistant human stomach-adenocarcinoma cell line.
    Son YS, Suh JM, Ahn SH, Kim JC, Yi JY, Hur KC, Hong WS, Muller MT, Chung IK.
    Cancer Chemother Pharmacol; 1998; 41(5):353-60. PubMed ID: 9523730
    [Abstract] [Full Text] [Related]

  • 5. Oxaliplatin in treatment of the cisplatin-resistant MKN45 cell line of gastric cancer.
    Tozawa K, Oshima T, Kobayashi T, Yamamoto N, Hayashi C, Matsumoto T, Miwa H.
    Anticancer Res; 2008; 28(4B):2087-92. PubMed ID: 18751380
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Characterization and resistance mechanisms of cisplatin-resistant human hepatocellular carcinoma cell line.
    Yang JX, Luo Y, Qiu HM, Tang WX.
    Saudi Med J; 2009 Jan; 30(1):35-40. PubMed ID: 19139770
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Characterization of a human squamous carcinoma cell line resistant to cis-diamminedichloroplatinum(II).
    Teicher BA, Holden SA, Kelley MJ, Shea TC, Cucchi CA, Rosowsky A, Henner WD, Frei E.
    Cancer Res; 1987 Jan 15; 47(2):388-93. PubMed ID: 3539321
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Establishment of cisplatin-resistant variants of human neuroblastoma cell lines, TGW and GOTO, and their drug cross-resistance profiles.
    Iwasaki I, Sugiyama H, Kanazawa S, Hemmi H.
    Cancer Chemother Pharmacol; 2002 Jun 15; 49(6):438-44. PubMed ID: 12107547
    [Abstract] [Full Text] [Related]

  • 14. Combined modalities of resistance in an oxaliplatin-resistant human gastric cancer cell line with enhanced sensitivity to 5-fluorouracil.
    Chen CC, Chen LT, Tsou TC, Pan WY, Kuo CC, Liu JF, Yeh SC, Tsai FY, Hsieh HP, Chang JY.
    Br J Cancer; 2007 Aug 06; 97(3):334-44. PubMed ID: 17609664
    [Abstract] [Full Text] [Related]

  • 15. Biological comparison of ovarian cancer resistant cell lines to cisplatin and Taxol by two different administrations.
    Yan XD, Li M, Yuan Y, Mao N, Pan LY.
    Oncol Rep; 2007 May 06; 17(5):1163-9. PubMed ID: 17390060
    [Abstract] [Full Text] [Related]

  • 16. Augmentation of transport for cisplatin-glutathione adduct in cisplatin-resistant cancer cells.
    Goto S, Yoshida K, Morikawa T, Urata Y, Suzuki K, Kondo T.
    Cancer Res; 1995 Oct 01; 55(19):4297-301. PubMed ID: 7671239
    [Abstract] [Full Text] [Related]

  • 17. cis-diamminedichloroplatinum(ii) resistance in vitro and in vivo in human embryonal carcinoma cells.
    Timmer-Bosscha H, Timmer A, Meijer C, de Vries EG, de Jong B, Oosterhuis JW, Mulder NH.
    Cancer Res; 1993 Dec 01; 53(23):5707-13. PubMed ID: 8242627
    [Abstract] [Full Text] [Related]

  • 18. Pretreatment with 5-fluorouracil enhances cytotoxicity and retention of DNA-bound platinum in a cisplatin resistant human ovarian cancer cell line.
    Tanaka T, Masuda H, Naito M, Tamai H.
    Anticancer Res; 2001 Dec 01; 21(4A):2463-9. PubMed ID: 11724308
    [Abstract] [Full Text] [Related]

  • 19. [Establishment of human ovarian cancer cisplatin resistant cell line COC1/DDP and its mechanism of resistance].
    Zhou Y, Chen H, Yang Q.
    Zhonghua Yi Xue Za Zhi; 1996 Sep 01; 76(9):680-3. PubMed ID: 9275551
    [Abstract] [Full Text] [Related]

  • 20. Human renal UOK130 tumor cells: a drug resistant cell line with highly selective over-expression of glutathione S-transferase-pi isozyme.
    Wang W, Liu G, Zheng J.
    Eur J Pharmacol; 2007 Jul 30; 568(1-3):61-7. PubMed ID: 17509556
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.